Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Transplant diagnostics industry 3600 synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Technology trends
2.6 Transplant type trends
2.7 Application trends
2.8 End-use trends
Chapter 3 Transplant Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing transplant procedures
3.2.1.2 Technological advancements
3.2.1.3 Increasing funding from public & private organizations for R&D
3.2.1.4 Rising popularity of transplant diagnostic tests
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of transplant
3.2.2.2 Lack of skilled professionals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By transplant type
3.3.4 By application
3.3.5 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, 2022
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Transplant Diagnostics Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Reagents
5.3 Instruments
Chapter 6 Transplant Diagnostics Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, by technology
6.2 Molecular Assays
6.2.1 Polymerase Chain Reaction (PCR)
6.2.2 Next-generation sequencing (NGS)
6.2.3 Microarrays
6.3 Non-Molecular Assays
6.3.1 Serological Assays
6.3.2 Mixed Lymphocyte Culture Assay
6.3.3 Flow Cytometry
Chapter 7 Transplant Diagnostics Market Size and Forecast, By Transplant Type (USD Million)
7.1 Key trends, by transplant type
7.2 Solid Organ Transplantation
7.3 Stem Cell Transplantation
7.4 Soft Tissue Transplantation
7.5 Bone Marrow Transplantation
Chapter 8 Transplant Diagnostics Market Size and Forecast, By Application (USD Million)
8.1 Key trends, by application
8.2 Pre-Transplantation Testing
8.3 Post-Transplantation Monitoring
Chapter 9 Transplant Diagnostics Market Size and Forecast, By End-use (USD Million)
9.1 Key trends, by end-use
9.2 Hospitals & Transplant Centers
9.3 Research Laboratories
9.4 Others
Chapter 10 Transplant diagnostics Market Size and Forecast, By Region (USD Million & Units)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Poland
10.3.7 Sweden
10.3.8 The Netherlands
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Thailand
10.4.7 Indonesia
10.4.8 Philippines
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Columbia
10.5.5 Chile
10.5.6 Peru
10.6 MEA
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Israel
10.6.5 Turkey
10.6.6 Iran
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 Becton, Dickinson and Company
11.3 BioGenuix
11.4 Biomérieux SA
11.5 Bio-Rad Laboratories Inc.
11.6 CareDx
11.7 F Hoffman-La Roche AG
11.8 GenDx
11.9 Hologic Inc.
11.10 Illumina Inc.
11.11 Immucor, Inc.
11.12 Linkage Biosciences
11.13 Olerup Ssp
11.14 Omixon Ltd.
11.15 Qiagen NV
11.16 Sigma-Aldrich
11.17 Thermo Fisher Scientific Inc.
